Evrom Cannalytech Overview
Evrom Cannalytech is specializing in the development of biostimulants tailored specifically for cannabis cultivation. Their patent-pending formulations enhance disease resistance and increase the production of cannabinoids and terpenoids in both greenhouse and outdoor settings. By utilizing pathogen-derived compounds, these biostimulants activate the plant's defense mechanisms, leading to healthier growth and improved yields.
Latest News
No news articles.
| Sector | Agriculture & Food Technologies |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | evromcannalytech.com/ |
Locations
Petah Tikva, Israel
Photos & Videos
No files yet
Evrom Cannalytech Business
Sector
Agriculture & Food TechnologiesAg TechGenetics & InputHealth Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisTarget Customer
—Core Technology
Materials & SubstancesTags (3)
medical-cannabisagtechbiotechnologyEvrom Cannalytech Financials
Evrom Cannalytech Lifecycle
Evrom Cannalytech News
0 articlesNo news articles.
Evrom Cannalytech Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Evrom Cannalytech Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 79/100 |
| Missing | sector, video or image, funding rounds, news, markets, not claimed |
| BI Verification | Maor Perlov |
| Creator | Maor Perlov |
| Creator email | maor.perlov@sncentral.org |
| Last update | 2025-03-17T00:00:00.000Z |
| Created | 2025-03-17T00:00:00.000Z |